Stock NOVO B NOVO NORDISK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Market Closed - Nasdaq Copenhagen
Other stock markets
 15:59:56 26/04/2024 BST 		5-day change 1st Jan Change
886.6 DKK +2.28% Intraday chart for Novo Nordisk A/S +2.36% +27.00%
04-25 NOVO NORDISK : JP Morgan gives a Buy rating ZD
04-25 Scholz promises support for pharma sector in Germany as Merck invests RE

Evolution of the average Target Price on Novo Nordisk A/S

Price target over the last 5 years

History of analyst recommendation changes

0b7c6f18828dc0b0e7590039c4c1.O0t4t247rPo2XAd7dMYVyfX4f2711f09W6hoBBd7JfU.Djkv4V5t2rhlEFM2BbM4hKyOEh2Xp89uMv0sQU9Ier0JMSjlBUPzlgElQg~c32d24ab0c1a6bc5cca8bd469ed09a43

Analyst Recommendations on Novo Nordisk A/S

NOVO NORDISK : JP Morgan gives a Buy rating ZD
NOVO NORDISK : Bernstein maintains a Buy rating ZD
BMO Capital Starts Novo Nordisk With Outperform Rating, $163 Price Target MT
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : Barclays maintains a Buy rating ZD
NOVO NORDISK : Berenberg remains Neutral ZD
NOVO NORDISK : Novo’s bag is full of pearls! Alphavalue
NOVO NORDISK : Barclays reiterates its Buy rating ZD
NOVO NORDISK : UBS sticks Neutral ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating ZD
NOVO NORDISK : Deutsche Bank reiterates its Buy rating ZD
NOVO NORDISK : Novo’s got a strong arsenal to go the distance Alphavalue
NOVO NORDISK : Buy rating from Barclays ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
NOVO NORDISK : JP Morgan reiterates its Buy rating ZD
NOVO NORDISK : UBS reiterates its Neutral rating ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
NOVO NORDISK : Receives a Buy rating from Deutsche Bank ZD
NOVO NORDISK : UBS reiterates its Neutral rating ZD
NOVO NORDISK : Berenberg sticks Neutral ZD
NOVO NORDISK : Berenberg remains Neutral ZD
NOVO NORDISK : Deutsche Bank reaffirms its Buy rating ZD
NOVO NORDISK : Barclays remains its Buy rating ZD
Forget about rate cuts... Our Logo
NOVO NORDISK : Jefferies reaffirms its Sell rating ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
886.6 DKK
Average target price
904.2 DKK
Spread / Average Target
+1.99%
High Price Target
1,120 DKK
Spread / Highest target
+26.33%
Low Price Target
530 DKK
Spread / Lowest Target
-40.22%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novo Nordisk A/S

JPMORGAN Richard Vosser
BERNSTEIN RESEARCH Florent Cespedes
BMO Capital
UBS Jo Walton
BARCLAYS Emily Field
alphavalue Abhishek Raval
BERENBERG Kerry Holford
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
JEFFERIES Peter Welford
Cantor Fitzgerald
DZ BANK Elmar Kraus
TD Cowen
Stifel Nicolaus
ODDO BHF
Berenberg Bank
CREDIT SUISSE Lorenzo Biasio
GOLDMAN SACHS Keyur Parekh
Morgan Stanley
BNP Paribas Exane
JPMorgan Chase
Guggenheim
Bryan, Garnier & Co.
Deutsche Bank Securities
DEUTSCHE BANK Emmanuel Papadakis
Liberum Capital
KEPLER CHEUVREUX David Evans
HSBC Stephen McGarry
INDEPENDENT RESEARCH Tobias Gottschalt
BANK OF AMERICA (BOFA) Sachin Jain

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. Consensus Novo Nordisk A/S